---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-021410"
form_type: "8-K"
ticker: "CING"
cik: "0001862150"
company_name: "Cingulate Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:37:41.090521+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Cingulate completes $6M debt financing, appoints Bryan Downey as CCO

## Summary
- Issued $6.57M unsecured promissory note at 9% interest, maturing 18 months, to Avondale Capital for $6M net proceeds.
- Bryan Downey appointed Chief Commercial Officer; granted 30,000 options at $3.80/share, vesting over 4 years.
- Cash runway extended into Q2 2026; proceeds for working capital and general corporate purposes.
- FDA accepted NDA for CTx-1301 (ADHD); PDUFA target action date May 31, 2026.
- Note includes monthly redemption up to $660k after PDUFA; company can defer up to 2 redemptions with 1% fee.

## SEC filing metadata
- accession: 0001493152-25-021410
- form_type: 8-K
- ticker: CING
- cik: 0001862150
- company_name: Cingulate Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1862150/000149315225021410/0001493152-25-021410-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1862150/000149315225021410/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-021410
- JSON: https://secwatch.observer/filing/0001493152-25-021410.json
- Plain text: https://secwatch.observer/filing/0001493152-25-021410.txt

## Key facts
- Debt Financings
  Cingulate Inc. incurred loan of $6,570,000 with Avondale Capital, LLC at 9% per annum maturing 18 months after its issuance date.
  - Instrument: loan
  - Principal: $6,570,000
  - Counterparty: Avondale Capital, LLC
  - Rate: 9% per annum
  - Maturity: 18 months after its issuance date
  - Event: incurrence
  source text: On November 7, 2025, Cingulate, Inc. (the “Company”), entered into a Note Purchase Agreement (the “Note Purchase Agreement”) with Avondale Capital, LLC, a Utah limited liability company (“Lender”), pursuant to which the Company issued and sold to Lender an unsecured promissory note (the “Note”) in the amount of $6,570,000 (the “Principal Amount”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1862150/000149315225021410/0001493152-25-021410-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.